OA01 LKB1 Pathway Variant TSC2 Rs30259 Predicts the Prognosis in Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Nuclear EGFR Protein Expression Predicts Poor Survival in Early Stage Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2013English

P1.03-29 an Intronic Variant in EGFR Regulates GBAS Expression and Predicts Survival in Early-Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

108P: Genetic Polymorphisms in Glycolytic Pathway Are Associated With the Prognosis of Patients With Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

Journal of Cancer
Oncology
2016English

Low Level of 5-Hydroxymethylcytosine Predicts Poor Prognosis in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Early-Stage Non-Small Cell Lung Cancer in Asian-Americans in the National Lung Screening Trial

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy